39 results
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
5 Apr 24
Regulation FD Disclosure
11:26am
(“PPARs”) are also considered potential therapeutic targets for neurodegenerative disorders such as AD. PPAR’s are ligand-activated transcription
8-K
EX-99.1
fylzptm
24 Oct 23
Regulation FD Disclosure
4:18pm
8-K
EX-99.1
4ldbb
1 Jun 23
InMed’s Neurodegenerative Disease Study Presented at Canadian Neuroscience Meeting
1:27pm
424B5
iddbl3cnn v8
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
zdqkblj kffbu2ao0
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
47l8g3
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
iexzg1h8 cfyqdmn2
7 Apr 22
Prospectus supplement
4:46pm